After three amended complaints, dozens of challenged statements, and years of post-IPO scrutiny, Allbirds, Inc. has secured a definitive victory: a dismissal with prejudice. In a newly-issued order, a federal court in California tossed the shareholder lawsuit accusing Allbirds and its executives of securities fraud in connection with its November 2021 IPO and subsequent public statements – and declined to give the plaintiffs another chance to replead. The ruling effectively ends a case that sought to transform the footwear company’s post-market stumble into a story of actionable deception.
The Background in Brief: A group of Allbirds shareholders filed suit in 2023, alleging that the company made misleading statements in connection with its November 2021 IPO and later disclosures, in violation of the Securities Act and Exchange Act. Specifically, investors alleged that Allbirds misled the market about its retail expansion, product strategy, and the durability of customer demand. The court dismissed two complaints, in May 2024 and June 2025, respectively, finding that the plaintiffs failed to adequately plead traceability and scienter.
By the time plaintiffs filed their third amended complaint in July 2025, their lawsuit had narrowed to two core issues: whether investors could properly trace their shares to the Allbirds IPO registration statement, and whether the plaintiffs had adequately pleaded scienter with respect to statements concerning Allbirds’ retail store expansion strategy and store-level performance.
The High Bar for IPO-Era Claims
In a February 26 order, Judge Araceli Martínez-Olguín of the Northern District of California sided with Allbirds again, finding that the plaintiffs still had not cured the core defects that plagued their earlier filings.
> On the Securities Act claims, the court held that investors again failed to adequately plead traceability. Because Allbirds’ IPO shares were commingled with other shares eligible for sale, plaintiffs were required to plausibly allege that the stock they purchased was issued pursuant to the allegedly misleading registration statement. Their statistical argument – that it was “mathematically negligible” they did not purchase at least one registered share – was insufficient under controlling Ninth Circuit precedent. Without concrete tracing allegations, the Section 11 claim failed, and the derivative Section 15 claim fell with it.
> The Exchange Act claims fared no better. Although plaintiffs attempted to bolster their scienter allegations with new details about internal meetings and retail performance reports, the court determined that many of the challenged statements about Allbirds’ stores amounted to non-actionable corporate optimism. Descriptions of “strong” store economics, “fantastic” launches, and confidence in post-pandemic rebounds were deemed classic puffery or protected opinion – not materially false statements of fact.
In other words, even if certain stores underperformed or expansion proved overly aggressive, that does not automatically translate into securities fraud. Absent a plausible allegation of a materially false or misleading statement and a strong inference of scienter, the Section 10(b) claim could not proceed.
Notably, the court denied leave for the plaintiffs to amend their complaint. After three rounds of pleadings and repeated guidance from the bench, the judge found further amendment of the lawsuit would be futile and dismissed the case with prejudice – bringing the Allbirds litigation to a close.
THE BOTTOM LINE: The ruling sheds light on the high bar investors face when attempting to reframe strategic missteps, shifting consumer demand, or retail growing pains as actionable securities fraud. For Allbirds, Inc., the decision draws a firm line between a difficult stretch as a newly public company and the type of deliberate deception required to sustain federal securities claims.
The case is Shnayder v. Allbirds, Inc., et al., 3:23-cv-01811 (N.D. Cal.).
Share
